InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
9
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-5.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Shukla Sanjay, Chief Executive Officer. Insider active across 2 companies, notably aTYR PHARMA INC. In total, 13 filings have been recorded. Breakdown: 9 buys · 0 sell. Total volume traded: €209k. Activity tracked since 18 May 2021. The latest transaction was disclosed on 31 May 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Shukla Sanjay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
10,375 sharesCommon StockSEC:0001193125-26-038007:0
10,375 sharesCommon StockSEC:0000950170-25-013891:0
20,000 shares@ US$1.80713.8% of flowCommon StockSEC:0000950170-24-067666:0
Canonical exit: 29 Aug 2024 (T+90)
10,375 sharesCommon stockSEC:0001209191-24-002949:0
3,000 shares@ US$1.171.3% of flowCommon StockSEC:0001209191-23-058377:0
Canonical exit: 10 Mar 2024 (T+90)
1,422 shares@ US$1.1380.6% of flowCommon StockSEC:0001209191-23-054976:0
Canonical exit: 8 Feb 2024 (T+90)
15,000 shares@ US$2.014911.4% of flowCommon StockSEC:0001209191-23-043943:0
Canonical exit: 26 Oct 2023 (T+90)
10,375 sharesCommon stockSEC:0001209191-23-007362:0
10,000 shares@ US$2.14058.6% of flowCommon StockSEC:0001209191-22-058295:0
Canonical exit: 19 Feb 2023 (T+90)
15,000 shares@ US$2.877617.0% of flowCommon StockSEC:0001209191-22-041230:0
Canonical exit: 29 Sept 2022 (T+90)
5,000 shares@ US$6.761314.3% of flowCommon StockSEC:0001209191-22-002768:0
Canonical exit: 7 Apr 2022 (T+90)
2,500 shares@ US$8.5759.0% of flowCommon StockSEC:0001209191-21-064565:0
Canonical exit: 13 Feb 2022 (T+90)
10,000 shares@ US$4.0115.7% of flowCommon StockSEC:0001209191-21-034292:0
Canonical exit: 16 Aug 2021 (T+90)
13 of 13 declarations
About Shukla Sanjay
Shukla Sanjay is Directeur Général and is linked to aTYR PHARMA INC, where he holds the role of President and CEO. He has 13 filings in total, all included in the recent sample, with acquisitions for EUR 209042 and no sales, over the period from 2021-05-20 to 2026-02-04.
